Efficacy of canagliflozin versus liraglutide, alternative to bolus insulin in patients with basal-bolus regimen.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 01 Dec 2017
At a glance
- Drugs Canagliflozin (Primary) ; Liraglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms ECLIPS
- 29 Nov 2017 Status changed from recruiting to active, no longer recruiting.
- 21 Oct 2015 New trial record